SDZXF:OTCMKTS
Sandoz Group AG
၈၄.၀၃ US$
၀.၀၀%
(၀.၀၀) 1D
စက် ၂၃, GMT-၄ ၁၅:၂၀:၀၇ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZXF...
Mkt. cap
ဋေ ၃.၀၇ ထ
Avg. vol.
၁၀၃.၀၀
Volume
၃၆.၀၀
52-wk high
၉၄.၅၅ US$
52-wk low
၆၀.၄၄ US$
Shares outstanding
၄၄.၀၀ ကုဋေ
No. of employees
၂ သောင်း
Mkt. cap
ဋေ ၃.၀၇ ထ
Avg. vol.
၁၀၃.၀၀
Volume
၃၆.၀၀
52-wk high
၉၄.၅၅ US$
52-wk low
၆၀.၄၄ US$
Shares outstanding
၄၄.၀၀ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၂၄ မိနစ်
Sandoz stock trades at EUR 74.52 with CHF 30.2 billion value
Medical Daily
·
ပြီးခဲ့သည့် ၃ ရက်
Consumers Who Bought Certain Generics From 2009 to 2019 Can Claim Share of $400 Million Sandoz Settlement
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG